Incremental impact of body mass status with modifiable unhealthy lifestyle behaviors on pharmaceutical expenditure
Saved in:
| Title: | Incremental impact of body mass status with modifiable unhealthy lifestyle behaviors on pharmaceutical expenditure |
|---|---|
| Authors: | Tae Hyun Kim, Eui Kyung Lee, Euna Han |
| Contributors: | Graduate School of Public Health, Tae Hyun Kim, Eui-Kyung Lee, Euna Han, Kim, Tae Hyun |
| Source: | Research in Social and Administrative Pharmacy. 12:990-1003 |
| Publisher Information: | Elsevier BV, 2016. |
| Publication Year: | 2016 |
| Subject Terms: | Adult, Male, Alcohol Drinking, Health Expenditures/statistics & numerical data, Health Behavior, Instrumental variable quantile regression model, Life Style, Overweight/economics, Overweight/obesity, Pharmaceutical expenditure, Body Mass Index, Alcohol Drinking/epidemiology, Young Adult, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Risk Factors, Republic of Korea, 80 and over, Humans, Obesity, Aged, Aged, 80 and over, 2. Zero hunger, Middle Aged, Overweight, Overweight/epidemiology, 3. Good health, Obesity/epidemiology, Unhealthy behavior, Obesity/economics, Regression Analysis, Female, Republic of Korea/epidemiology, Health Expenditures |
| Description: | Overweight/obesity is a growing health risk in Korea. The impact of overweight/obesity on pharmaceutical expenditure can be larger if individuals have multiple risk factors and multiple comorbidities. The current study estimated the combined effects of overweight/obesity and other unhealthy behaviors on pharmaceutical expenditure.An instrumental variable quantile regression model was estimated using Korea Health Panel Study data. The current study extracted data from 3 waves (2009, 2010, and 2011).The final sample included 7148 person-year observations for adults aged 20 years or older. Overweight/obese individuals had higher pharmaceutical expenditure than their non-obese counterparts only at the upper quantiles of the conditional distribution of pharmaceutical expenditure (by 119% at the 90th quantile and 115% at the 95th). The current study found a stronger association at the upper quantiles among men (152%, 144%, and 150% at the 75th, 90th, and 95th quantiles, respectively) than among women (152%, 150%, and 148% at the 75th, 90th, and 95th quantiles, respectively). The association at the upper quantiles was stronger when combined with moderate to heavy drinking and no regular physical check-up, particularly among males.The current study confirms that the association of overweight/obesity with modifiable unhealthy behaviors on pharmaceutical expenditure is larger than with overweight/obesity alone. Assessing the effect of overweight/obesity with lifestyle risk factors can help target groups for public health intervention programs. |
| Document Type: | Article |
| Language: | English |
| ISSN: | 1551-7411 |
| DOI: | 10.1016/j.sapharm.2015.12.009 |
| Access URL: | https://pubmed.ncbi.nlm.nih.gov/26810936 https://www.ncbi.nlm.nih.gov/pubmed/26810936 https://pubmed.ncbi.nlm.nih.gov/26810936/ https://ir.ymlib.yonsei.ac.kr/handle/22282913/152543 https://www.sciencedirect.com/science/article/abs/pii/S1551741115002831 https://yonsei.pure.elsevier.com/en/publications/incremental-impact-of-body-mass-status-with-modifiable-unhealthy- https://europepmc.org/abstract/MED/26810936 |
| Rights: | Elsevier TDM CC BY NC ND |
| Accession Number: | edsair.doi.dedup.....9ebf946d0489a9155ad28896429f805c |
| Database: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Overweight/obesity is a growing health risk in Korea. The impact of overweight/obesity on pharmaceutical expenditure can be larger if individuals have multiple risk factors and multiple comorbidities. The current study estimated the combined effects of overweight/obesity and other unhealthy behaviors on pharmaceutical expenditure.An instrumental variable quantile regression model was estimated using Korea Health Panel Study data. The current study extracted data from 3 waves (2009, 2010, and 2011).The final sample included 7148 person-year observations for adults aged 20 years or older. Overweight/obese individuals had higher pharmaceutical expenditure than their non-obese counterparts only at the upper quantiles of the conditional distribution of pharmaceutical expenditure (by 119% at the 90th quantile and 115% at the 95th). The current study found a stronger association at the upper quantiles among men (152%, 144%, and 150% at the 75th, 90th, and 95th quantiles, respectively) than among women (152%, 150%, and 148% at the 75th, 90th, and 95th quantiles, respectively). The association at the upper quantiles was stronger when combined with moderate to heavy drinking and no regular physical check-up, particularly among males.The current study confirms that the association of overweight/obesity with modifiable unhealthy behaviors on pharmaceutical expenditure is larger than with overweight/obesity alone. Assessing the effect of overweight/obesity with lifestyle risk factors can help target groups for public health intervention programs. |
|---|---|
| ISSN: | 15517411 |
| DOI: | 10.1016/j.sapharm.2015.12.009 |